Healthpoint, DFB to pay up to $48M in drug case
Healthpoint Ltd. and DFB Pharmaceuticals will pay up to $48 million to settle allegations that Healthpoint marketed a prescription skin ointment without approval from federal regulators.
Join the discussion below, or Read more at Star-Telegram.com.
#1 Dec 6, 2012
THe FDA will be miffed it wasn't allowed to approve this faulty, fraudulent product like it does all the other killer drugs.
Add your comments below
|pijat / massage panggilan bandung professional ...||2 hr||ANA AULIA||1|
|New Authorization For Needle Exchange In Pittsf...||17 hr||Cops are degenerates||3|
|Researchers find gene that might limit desire t...||20 hr||Stephany McDowell||1|
|Bronx residents mixed on federal smoking ban in...||22 hr||Ben||3|
|Charlie Sheen decides to end hostilities agains... (Nov '13)||Fri||Ann||4|
|Pediatrician group wants government to protect ...||Fri||Fraid Not||3|
|Herpes Infects 19 Million People per Year; CBCD... (Jun '15)||Fri||Come4It||5|
|Pregnancy Symptoms - 12 Very Early Symptoms of ... (Jun '07)||Thu||Nic123||7,014|
Find what you want!
Search Health Forum Now
Copyright © 2016 Topix LLC